Real‐world retrospective study of KRAS mutations in advanced non–small cell lung cancer in the era of immunotherapy
Sign Up to like & getrecommendations! Published in 2023 at "Cancer"
DOI: 10.1002/cncr.34731
Abstract: KRAS mutation‐positive (KRAS‐positive), advanced nonsmall‐cell lung cancer (NSCLC) is characterized by a poor prognosis. KRAS mutations are extremely heterogeneous from a biologic point of view, and real‐world data by mutation subtype in the era of… read more here.
Keywords: lung cancer; cancer; kras mutations; real world ... See more keywords
Hepatocellular carcinoma in the era of immunotherapy.
Sign Up to like & getrecommendations! Published in 2018 at "Current problems in cancer"
DOI: 10.1016/j.currproblcancer.2017.10.007
Abstract: Hepatocellular carcinoma is a common malignancy which usually emerges on a background of chronic liver disease. Unfortunately, with contemporary management, patients with advanced hepatocellular carcinoma have few treatment options, and prognosis is poor. The emergence… read more here.
Keywords: hepatocellular carcinoma; carcinoma; carcinoma era; era immunotherapy ... See more keywords
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12061473
Abstract: The treatment of multiple myeloma (MM) has entered into a new era of immunotherapy. Novel immunotherapies will significantly improve patient outcome via simultaneously targeting malignant plasma cell (PC) and reversing immunocompromised bone marrow (BM) microenvironment.… read more here.
Keywords: multiple myeloma; new era; bcma; era immunotherapy ... See more keywords